February 11, 2025 - 12:17

A federal judge has issued a temporary restraining order to pause funding cuts to public health research that were implemented by the Trump administration. This ruling specifically affects 22 states led by Democratic governors, who filed a lawsuit contesting the reductions in funding. The judge's decision emphasizes the importance of maintaining adequate financial support for public health initiatives, particularly during a time when many communities are facing significant health challenges.
The cuts had raised concerns among health officials and researchers, who argued that reduced funding could hinder vital public health programs and research efforts. The lawsuit highlighted the potential negative impact on health outcomes, especially in areas such as disease prevention and health equity. As the legal battle continues, the ruling serves as a temporary relief for the affected states, allowing them to sustain their public health research initiatives while the case is further examined in court. The outcome of this legal challenge could have lasting implications for public health funding across the nation.
November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...